fromPinkNews | Latest lesbian, gay, bi and trans news | LGBTQ+ news
2 days agoStreeting pressed on 'gender-critical' doctor's role in puberty blockers pause
Good Law Project revealed on Thursday (12 March) that the Department of Health and Social Care (DHSC) temporarily halted the upcoming PATHWAYS trial because of concerns raised by cardiology physician professor Jacob George. The £10 million study, headed by King's College London (KCL), was designed to analyse the effects of puberty suppressant hormones, known as puberty blockers, on transgender youngsters.
Public health

